Journal of Controlled Release · 2022 · 36 citations · 52 references
PharmacyImmunologyMolecular PharmaceuticsDrug DeliveryVaccine ImmunologyVaccinologyNanomedicineNucleic Acid VaccinesVaccinationVaccine DeliveryVaccine Delivery SystemsVaccine PlatformsAntigen Co-deliveryDrug Co-deliveryNanoformulated VaccinesNanoparticle Vaccine DeliveryNanoparticle Vaccine FormulationsNanoparticle Vaccine PlatformsNanovaccines
52
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott, Zhuting Hu, Derin B. Keskin et al. · Nature · 2017 · 2.9K citations
Medicine, Immunology, Oncology +12
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter, Mathias Vormehr, Niels van de Roemer et al. · Nature · 2015 · 1.2K citations · Full text
Life Sciences, Immunology, Oncology +14
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu, Kelly D. Moynihan, Yiran Zheng et al. · Nature · 2014 · 941 citations
A STING-activating nanovaccine for cancer immunotherapy
Min Luo, Hua Wang, Zhaohui Wang et al. · Nature Nanotechnology · 2017 · 889 citations
Life Sciences, Immunology, Oncology +14
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach, Danielle M. Lussier, Alexander P. Miceli et al. · Nature · 2019 · 870 citations · Full text
Medicine, Cancer Biology, Immunology +14